Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,2 USD | -2,80% | -2,80% | +10,64% |
Vakgebied
Aantal werknemers: 7
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Oren Gilad
CEO | Chief Executive Officer | 56 | 01-05-22 |
John Hamill
DFI | Director of Finance/CFO | 60 | 30-01-23 |
Zeev Weiss
PRN | Corporate Officer/Principal | 62 | 01-05-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 01-01-15 |
John Henneman
BRD | Director/Board Member | 62 | 01-08-19 |
Rifat Pamukcu
BRD | Director/Board Member | 66 | 01-05-22 |
Jean Bizzari
BRD | Director/Board Member | 69 | 23-08-23 |
Oren Gilad
CEO | Chief Executive Officer | 56 | 01-05-22 |
Marc Duey
BRD | Director/Board Member | 68 | 01-05-22 |
Richard Peters
CHM | Chairman | 61 | 30-06-20 |
Director/Board Member | 70 | 01-05-22 | |
Gabriela Gruia
BRD | Director/Board Member | 67 | 05-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 56 227 | 0 | 0 | 83,50 % |
Aandeel B | 1 | 5 430 215 | 4 534 187 ( 83,50 %) | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,64% | 28,24 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers APRE
- Onderneming Aprea Therapeutics, Inc.